Nina Weichert‐Leahey

1.4k total citations
10 papers, 427 citations indexed

About

Nina Weichert‐Leahey is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Nina Weichert‐Leahey has authored 10 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Neurology and 3 papers in Genetics. Recurrent topics in Nina Weichert‐Leahey's work include Neuroblastoma Research and Treatments (6 papers), Protein Degradation and Inhibitors (3 papers) and Virus-based gene therapy research (2 papers). Nina Weichert‐Leahey is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Protein Degradation and Inhibitors (3 papers) and Virus-based gene therapy research (2 papers). Nina Weichert‐Leahey collaborates with scholars based in United States, China and Australia. Nina Weichert‐Leahey's co-authors include Richard A. Young, Brian J. Abraham, A. Thomas Look, Adam D. Durbin, Mark W. Zimmerman, Shuning He, Zhaodong Li, Jinghui Zhang, Yu Liu and Shizhen Zhu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Nature Genetics.

In The Last Decade

Nina Weichert‐Leahey

7 papers receiving 427 citations

Peers

Countries citing papers authored by Nina Weichert‐Leahey

Since Specialization

Citations

This map shows the geographic impact of Nina Weichert‐Leahey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Weichert‐Leahey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Weichert‐Leahey more than expected).

Fields of papers citing papers by Nina Weichert‐Leahey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Weichert‐Leahey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Weichert‐Leahey. The network helps show where Nina Weichert‐Leahey may publish in the future.

Co-authorship network of co-authors of Nina Weichert‐Leahey

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Weichert‐Leahey. A scholar is included among the top collaborators of Nina Weichert‐Leahey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Weichert‐Leahey. Nina Weichert‐Leahey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance 2025 ·Blood ·Lara Wahlster, Lucy A. Godley, Jason X. Cheng, Michael W. Drazer, Christopher R. Reilly, Geraldine S. Pinkus, Jared H. Rowe, Nina Weichert‐Leahey, R. Grant Rowe, (unknown), (unknown), Franziska Wachter, (unknown), Alan D. Michelson, Alan Cantor, Akiko Shimamura, Jacob R. Bledsoe	0
2	Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series 2024 ·Blood ·Lara Wahlster, Jared H. Rowe, Nina Weichert‐Leahey, R. Grant Rowe, (unknown), Lucy A. Godley, Jason X. Cheng, Michael W. Drazer, Christopher R. Reilly, Alan D. Michelson, Alan Cantor, Akiko Shimamura, Jacob R. Bledsoe	0
3	Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state 2023 ·Journal of Clinical Investigation ·Nina Weichert‐Leahey, Hui Shi, Ting Tao, Derek A. Oldridge, Adam D. Durbin, Brian J. Abraham, Mark W. Zimmerman, Shizhen Zhu, Andrew Wood, Deepak Reyon, J. Keith Joung, Richard A. Young, Sharon J. Diskin, John M. Maris, A. Thomas Look	8
4	MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation 2021 ·Cancers ·(unknown), Mark W. Zimmerman, Nina Weichert‐Leahey, (unknown), Belamy B. Cheung, Brian J. Abraham, Anneleen Beckers, Pieter‐Jan Volders, Bieke Decaesteker, Daniel R. Carter, (unknown), Katleen De Preter, Wouter Van Loocke, Glenn M. Marshall, Adam D. Durbin, Frank Speleman, Kaat Durinck	9
5	Alveolar rhabdomyosarcoma presenting as a pleural effusion: An atypical presentation of a malignancy 2020 ·Pediatric Pulmonology ·(unknown), (unknown), Nina Weichert‐Leahey, Jennifer W. Mack, Meera Subramaniam	0
6	ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry 2019 ·Nature Communications ·Lu Wang, Tze King Tan, Adam D. Durbin, Mark W. Zimmerman, Brian J. Abraham, Shi Hao Tan, Phuong Cao Thi Ngoc, Nina Weichert‐Leahey, Koshi Akahane, Lee N. Lawton, Jo Lynne Rokita, John M. Maris, Richard A. Young, A. Thomas Look, Takaomi Sanda	54
7	Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry 2018 ·Nature Genetics ·Adam D. Durbin, Mark W. Zimmerman, Neekesh V. Dharia, Brian J. Abraham, Amanda Balboni Iniguez, Nina Weichert‐Leahey, Shuning He, John M. Krill-Burger, David E. Root, Francisca Vázquez, Aviad Tsherniak, William C. Hahn, Todd R. Golub, Richard A. Young, A. Thomas Look, Kimberly Stegmaier	145
8	c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification 2018 ·PMC ·Mark W. Zimmerman, Yu Liu, Shuning He, Adam D. Durbin, Brian J. Abraham, John M. Easton, Ying Shao, Beisi Xu, Shizhen Zhu, Xiaoling Zhang, Zhaodong Li, Nina Weichert‐Leahey, Richard A. Young, Jinghui Zhang, A. Thomas Look	2
9	MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification 2017 ·Cancer Discovery ·Mark W. Zimmerman, Yu Liu, Shuning He, Adam D. Durbin, Brian J. Abraham, John Easton, Ying Shao, Beisi Xu, Shizhen Zhu, Xiaoling Zhang, Zhaodong Li, Nina Weichert‐Leahey, Richard A. Young, Jinghui Zhang, A. Thomas Look	147
10	Small genomic insertions form enhancers that misregulate oncogenes 2017 ·Nature Communications ·Brian J. Abraham, Denes Hnisz, Abraham S. Weintraub, Nicholas Kwiatkowski, Charles H. Li, Zhaodong Li, Nina Weichert‐Leahey, Sunniyat Rahman, Yu Liu, Julia Etchin, Benshang Li, Shuhong Shen, Tong Ihn Lee, Jinghui Zhang, A. Thomas Look, Marc R. Mansour, Richard A. Young	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact